HIMS

34.10

0.61% -0.21

Dopo l'orario di chiusura: 33.92 -0.18 -0.53%

Hims Hers Health Inc (HIMS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HIMS Giù? Forum Previsione

Precedente Chiudi:

$34.31

Aprire:

$34.06

Volume 24 ore:

9.13M

Relative Volume:

0.40

Capitalizzazione di mercato:

$7.76B

Reddito:

$1.78B

Utile/perdita netta:

$164.40M

Rapporto P/E:

49.42

EPS:

0.69

Flusso di cassa netto:

$236.51M

1 W Prestazione:

-2.71%

1M Prestazione:

-14.24%

6M Prestazione:

-30.99%

1 anno Prestazione:

+28.39%

Intervallo 1D:

$33.80

$34.75

Intervallo di 1 settimana:

$33.50

$35.14

Portata 52W:

$23.97

$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Nome

Hims Hers Health Inc

Settore

Healthcare (1131)

Industria

Drug Manufacturers - Specialty & Generic (85)

Telefono

415-851-0195

Indirizzo

2269 CHESTNUT ST, SAN FRANCISCO

Dipendente

1,637

Cinguettio

Prossima data di guadagno

2025-02-24

Ultimi documenti SEC

HIMS's Discussions on Twitter

Confronta HIMS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HIMS Hims Hers Health Inc	34.10	7.81B	1.78B	164.40M	236.51M	0.69
ZTS Zoetis Inc	125.98	55.63B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	15.76	49.44B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.09	45.11B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.56	36.59B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	502.90	21.84B	3.08B	1.24B	1.07B	25.61

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Overweight
2025-10-21	Iniziato	KeyBanc Capital Markets	Sector Weight
2025-06-23	Downgrade	Needham	Buy → Hold
2025-06-04	Reiterato	Needham	Buy
2025-04-29	Downgrade	TD Cowen	Buy → Hold
2025-02-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Downgrade	Citigroup	Neutral → Sell
2025-01-07	Iniziato	BTIG Research	Buy
2024-12-17	Iniziato	Morgan Stanley	Overweight
2024-11-14	Downgrade	BofA Securities	Buy → Underperform
2024-08-22	Iniziato	Needham	Buy
2024-08-09	Downgrade	Imperial Capital	Outperform → In-line
2024-05-22	Downgrade	Citigroup	Buy → Neutral
2024-04-16	Downgrade	Jefferies	Buy → Hold
2024-04-10	Iniziato	Canaccord Genuity	Buy
2024-02-28	Aggiornamento	Imperial Capital	In-line → Outperform
2024-02-26	Iniziato	Leerink Partners	Market Perform
2023-12-07	Iniziato	Imperial Capital	In-line
2023-07-28	Iniziato	TD Cowen	Outperform
2023-04-11	Iniziato	Robert W. Baird	Neutral
2023-02-09	Aggiornamento	Jefferies	Hold → Buy
2022-11-08	Aggiornamento	BofA Securities	Neutral → Buy
2022-11-08	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Downgrade	Piper Sandler	Overweight → Neutral
2022-09-07	Iniziato	Truist	Hold
2022-07-15	Iniziato	SVB Leerink	Underperform
2022-04-14	Iniziato	Guggenheim	Buy
2022-04-01	Ripresa	Credit Suisse	Outperform
2022-03-10	Iniziato	Deutsche Bank	Hold
2021-12-02	Iniziato	Jefferies	Hold
2021-11-11	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-07-06	Iniziato	BofA Securities	Neutral
2021-05-20	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-04-21	Iniziato	Truist	Hold
2021-03-09	Iniziato	Credit Suisse	Neutral
2021-03-02	Aggiornamento	Citigroup	Neutral → Buy
2021-02-17	Iniziato	Citigroup	Neutral
2021-02-12	Iniziato	Piper Sandler	Neutral
2021-02-08	Iniziato	Tigress Financial	Buy

Mostra tutto

Hims Hers Health Inc Borsa (HIMS) Ultime notizie

02:09 AM

Best Healthcare Stocks Worth WatchingDecember 29th - MarketBeat

02:09 AM

12:35 PM

Hims & Hers Health Stock (HIMS) Opinions on Canadian Market Expansion - Quiver Quantitative

12:35 PM

10:30 AM

Top 10 Most Shorted Stocks: Lucid, MARA, Hims and More - Benzinga

10:30 AM

10:01 AM

TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside - Finviz

10:01 AM

02:26 AM

Hims & Hers stock slides into year-end as investors weigh Ohio buildout and macro calendar - ts2.tech

02:26 AM

Dec 28, 2025

Returns Recap: Why hedge funds are buying Hims Hers Health Inc stockBuy Signal & Expert Approved Momentum Ideas - moha.gov.vn

Dec 28, 2025

Dec 27, 2025

Hims & Hers: A Growth Story Battling Market Skepticism - AD HOC NEWS

Dec 27, 2025

Carnegie Investment Counsel Acquires 61,560 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat

Dec 27, 2025

Dec 26, 2025

Hims & Hers Health, Inc. (NYSE:HIMS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat

Dec 26, 2025

Dec 24, 2025

Assessing Hims and Hers After Its 462% Multi Year Surge and Premium Valuation Multiple - Yahoo Finance

Dec 24, 2025

HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? - Finviz

Dec 24, 2025

The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - The Globe and Mail

Dec 24, 2025

Hims & Hers Hit A GLP-1 Speed Bump This Year — But Growth Is Just Cooling, Not Cracking - Stocktwits

Dec 24, 2025

Hims & Hers Health Stock (HIMS) Opinions on Recent Volatility and Expansion - Quiver Quantitative

Dec 24, 2025

Voya Investment Management LLC Buys 52,370 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat

Dec 24, 2025

Hims & Hers quietly scooped up nearly 300,000 square feet in East Valley - The Business Journals

Dec 24, 2025

New Albany gains $200M health care expansion, 400 new jobs - Yahoo

Dec 24, 2025

Dec 23, 2025

Oluyemi Okupe Sells 23,090 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat

Dec 23, 2025

3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail

Dec 23, 2025

Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows - The Globe and Mail

Dec 23, 2025